IPO Ideas
Menu

IPO market

GMPSubscriptionBlogs
Unlisted IdeasIPO Ideas
About Us
Sudeep Pharma Limited IPO logo

Sudeep Pharma Limited IPO

BBMainboardBSE,NSEListed
Listed at
730
+23.10%

Sudeep Pharma Limited IPO is a Mainboard book building IPO. Issue size is 895.00 Cr. Price band is ₹563 to ₹593 per share. Minimum investment is ₹14,825. Lot size is 25 shares. Open from 21 Nov 2025 to 25 Nov 2025. Allotment on 26 Nov 2025. Listing on 28 Nov 2025 at BSE,NSE. Managed by ICICI Securities Ltd.,IIFL Capital Services Ltd.. Registrar: MUFG Intime India Private Limited (Link Intime). Key details for GMP, subscription, price, allotment, and listing in one place.

Official documents: RHP and DRHP.

Sudeep Pharma Limited IPO overview

Sudeep Pharma Limited IPO Key figures

Price band, lot, minimum application, and issue window at a glance.

Price band
₹563 to ₹593
Lot size
25 shares / lot
Min investment
₹14,825
Issue open – close
21 Nov 2025 → 25 Nov 2025

Sudeep Pharma Limited IPO important dates

Issue Opens
21 Nov 2025
Issue Closes
25 Nov 2025
Allotment
26 Nov 2025
Listing
28 Nov 2025

Sudeep Pharma Limited IPO lot size

CategoryLotsSharesAmount
Retail (Min)125₹14,825
Retail (Max)13325₹1,92,725
S-HNI (Min)14350₹2,07,550
S-HNI (UPI)33825₹4,89,225
S-HNI (Max)671,675₹9,93,275
B-HNI (Min)681,700₹10,08,100

About Sudeep Pharma Limited IPO

From the company / RHP narrative.

Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.

The company operates six manufacturing facilities with a combined production capacity of 50,000 MT, specializing in minerals such as calcium, iron, magnesium, zinc, potassium, and sodium 

The company supplies more than 200 products to a diverse customer base across pharma, food, and nutrition sectors

The company has strong R&D capabilities with in-house labs and pilot-scale facilities focused on mineral salts and excipients.

Product Portfolio:


Pharmaceutical, Food and Nutrition Business
Specialty Ingredients Business
Triturates


As of December 31, 2024, the company had 704 permanent employees.

Competitve Strengths:


Market leadership with a diversified product portfolio in a high barrier industry
Distinguished global customer base with long-standing relationships with key customers
Well-equipped and regulatory compliant Manufacturing Facilities
Strong research and development capabilities

Objective of the issue

How the issuer plans to use IPO proceeds.

Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility I

General corporate purposes
Sudeep Pharma Limited IPO FAQs
A quick overview of key terms, dates, and how to track this IPO.

Documents & links

Prospectus, draft filings, and company site open in a new tab.

RHPDHRPCompany website

Registrar

Details about the registrar of the issue.

Registrar Name
MUFG Intime India Private Limited (Link Intime)
Email
oswalpumps.ipo@linkintime.co.in
Phone
2249186270
Address
Link Intime India Private Ltd C 101, 247 Park, L.B.S.Marg, Vikhroli (West), Mumbai - 400083
Website
https://linkintime.co.in/Initial_Offer/public-issues.html

Issue details

Key details about the issue, including the face value, lot size, and minimum investment.

Issue Type
BB
Face Value
1
Lead Managers
ICICI Securities Ltd.,IIFL Capital Services Ltd.
Min Quantity
25
Company Promoters
Sujit Jaysukh Bhayani,Avani Sujit Bhayani,Shanil Sujit Bhayani,Sujeet Jaysukh Bhayani HUF,Riva Resources Private Limited,,Bhayani Family Trust are the promoters of the company.
Website
https://www.sudeeppharma.com/
Email
cs.sudeep@sudeepgroup.com
Phone
+91 265 284 0656
Address
Sudeep Pharma Ltd. 129/1/A, GIDC Estate, Nandesari, Vadodara, Gujarat, 391340

Related articles

Research posts and updates that reference this company or theme.

Follow IPO & unlisted research in the app, available on iOS and Android.

Google PlayApp Store